Literature DB >> 9202258

Cerebral arteriovenous oxygen difference: a predictor of cerebral infarction and outcome in patients with severe head injury.

P D Le Roux1, D W Newell, A M Lam, M S Grady, H R Winn.   

Abstract

Jugular bulb oxygen monitoring can be used to estimate the adequacy of cerebral blood flow to support cerebral metabolism after severe head injury. In the present study, the authors studied the cerebral arteriovenous oxygen difference (AVDO[2]) before and after treatment in 32 head-injured patients (Glasgow Coma Scale scores < or = 8) to examine the relationships among AVDO and cerebral perfusion pressure (CPP), delayed cerebral infarction, and outcome. Fifteen patients (Group A) underwent craniotomy for hematoma evacuation and 17 (Group B) received mannitol for sustained intracranial hypertension (intracranial pressure > 20 mm Hg, > 10 minutes). Radiographic evidence of delayed cerebral infarction was observed in 14 patients. Overall, 17 patients died or were severely disabled. Cerebral AVDO(2) was elevated before craniotomy or mannitol administration; the mean AVDO(2) for all patients before treatment was 8.6 +/- 1.8 vol%. Following craniotomy or mannitol administration, the AVDO(2) decreased in 27 patients and increased in five patients (mean AVDO(2) 6.2 +/- 2.1 vol% in all patients; 6 +/- 1.9 vol% in Group A; and 6.4 +/- 2.4 vol% in Group B). The mean CPP was 75 +/- 9.8 mm Hg and no relationship with AVDO(2) was demonstrated. Before treatment, the AVDO(2) was not associated with delayed cerebral infarction or outcome. By contrast, a limited improvement in elevated AVDO(2) after craniotomy or mannitol administration was significantly associated with delayed cerebral infarction (Group A: p < 0.001; Group B: p < 0.01). Similarly, a limited improvement in elevated AVDO(2) after treatment was significantly associated with an unfavorable outcome (Group A: p < 0.01; Group B: p < 0.001). In conclusion, these findings strongly indicate that, despite adequate cerebral perfusion, limited improvement in elevated cerebral AVDO(2) after treatment consisting of either craniotomy or mannitol administration may be used to help predict delayed cerebral infarction and poor outcome after traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202258     DOI: 10.3171/jns.1997.87.1.0001

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen.

Authors:  Michael F Stiefel; Alejandro M Spiotta; Joshua D Udoetuk; Eileen Maloney-Wilensky; John B Weigele; Robert W Hurst; Peter D LeRoux
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Cerebral blood flow, brain tissue oxygen, and metabolic effects of decompressive craniectomy.

Authors:  Christos Lazaridis; Marek Czosnyka
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

3.  Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury. Part 2: Relationship with clinical, physiological, and treatment factors.

Authors:  Anthony A Figaji; Eugene Zwane; Crispin Thompson; A Graham Fieggen; Andrew C Argent; Peter D Le Roux; Jonathan C Peter
Journal:  Childs Nerv Syst       Date:  2009-02-13       Impact factor: 1.475

4.  Efficacy of reductive ventricular osmotherapy in a swine model of traumatic brain injury.

Authors:  Rick M Odland; Sandya Venugopal; John Borgos; Valerie Coppes; Alexander M McKinney; Gaylan Rockswold; Jian Shi; Scott Panter
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

Review 5.  Brain tissue oxygen-based therapy and outcome after severe traumatic brain injury: a systematic literature review.

Authors:  Raj Nangunoori; Eileen Maloney-Wilensky; Michael Stiefel; Soojin Park; W Andrew Kofke; Joshua M Levine; Wei Yang; Peter D Le Roux
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

6.  My paper 20 years later: cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins.

Authors:  N Stocchetti; S Magnoni; E R Zanier
Journal:  Intensive Care Med       Date:  2015-01-23       Impact factor: 17.440

Review 7.  Mitochondrial damage: a target for new therapeutic horizons.

Authors:  Jean F Soustiel; Sarit Larisch
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 8.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 9.  Brain Multimodality Monitoring: Updated Perspectives.

Authors:  David Roh; Soojin Park
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

10.  Analysis of high-frequency PbtO2 measures in traumatic brain injury: insights into the treatment threshold.

Authors:  Ryan Hirschi; Gregory W J Hawryluk; Jessica L Nielson; J Russell Huie; Lara L Zimmermann; Rajiv Saigal; Quan Ding; Adam R Ferguson; Geoffrey Manley
Journal:  J Neurosurg       Date:  2018-10-01       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.